1. A crossover study of risperidone in children, adolescents and adults with mental retardation.
- Author
-
Hellings JA, Zarcone JR, Reese RM, Valdovinos MG, Marquis JG, Fleming KK, and Schroeder SR
- Subjects
- Adolescent, Adult, Antipsychotic Agents therapeutic use, Child, Cross-Over Studies, Double-Blind Method, Female, Humans, Intellectual Disability epidemiology, Male, Middle Aged, Risperidone therapeutic use, Aggression psychology, Antipsychotic Agents adverse effects, Autistic Disorder epidemiology, Autistic Disorder psychology, Intellectual Disability psychology, Mental Disorders drug therapy, Mental Disorders epidemiology, Risperidone adverse effects, Weight Gain drug effects
- Abstract
Risperidone has shown safety and efficacy for aggressive and destructive behaviors in short-term studies. This longer-duration study includes a broad sample. Forty subjects, aged 8-56 years (mean=22), all with mental retardation and 36 with autism spectrum disorders participated in this 22-week crossover study, with 24 weeks of open maintenance thereafter. Of 40 subjects, 23 (57.5%) responded fully (50% decrease in Aberrant Behavior Checklist-Community Irritability subscale score), while 35 subjects (87.5%) showed a 25% decrease. Gender, mood disorder, and antiseizure medications did not alter response. Increased appetite and weight gain were common. Low dose risperidone was effective for aggressive behavior in persons with MR. More long-term studies are needed, incorporating weight control interventions.
- Published
- 2006
- Full Text
- View/download PDF